Barcelona Clinical Coordinating Center (BCCC), acting as the national coordinating contract research organization (CRO) for Spain, celebrates the successful completion of patient recruitment in the PRIMARY study evaluating the long-term safety and effectiveness of transcatheter edge-to-edge repair (TEER) compared with surgical repair in patients with primary degenerative mitral regurgitation. Sponsored by the National Institutes of… Read more »

The CHOICE-2 randomized clinical trial, coordinated by Hospital Clínic Barcelona and IDIBAPS, has been published in JAMA (Journal of American Medical Association). The study demonstrates that administering intra-arterial alteplase immediately after mechanical thrombectomy significantly improves functional outcomes in severe ischemic stroke. The centralized analysis of brain imaging data across the 14-site Spanish trial was conducted by the BCCC Imaging Core Lab.  Key Results  Among the 440 patients enrolled,… Read more »

Barcelona Clinical Coordinating Center (BCCC), the lead non-profit contract research organization (CRO) coordinating patient recruitment and clinical operations, announces the completion of patient enrollment in the ANGIODAPT-01 trial, a randomized controlled study evaluating an abbreviated dual antiplatelet therapy (DAPT) regimen following drug-eluting stent implantation. The trial has been sponsored by iVascular, a company developing innovative… Read more »

Barcelona Clinical Coordinating Center (BCCC), the non-profit contract research organization responsible for clinical coordination and patient recruitment, announces the completion of enrollment in the OPAL study, a first-in-human and pivotal clinical study evaluating the novel embolic liquid system Amber, sponsored by iVascular, a company developing innovative advanced medical devices and therapies for the treatment of… Read more »

The European Commission has announced the opening of the new Joint Scientific Consultations (JSCs) periods under EU Health Technology Assessment (HTA) Regulation (Regulation (EU) 2021/2282) (sourced link). JSCs enable health technology developers to obtain coordinated, EU-level feedback while planning clinical studies, focused on the evidence needs for a potential future Joint Clinical Assessment (JCA). JSCs… Read more »

The EIC Access + is a program that provides financial support to EIC beneficiaries to access expert business services and support their growth.